Goldman Sachs BDC (NYSE:GSBD – Get Free Report) is projected to release its Q1 2025 earnings data after the market closes on Thursday, May 8th. Analysts expect Goldman Sachs BDC to post earnings of $0.43 per share and revenue of $101.12 million for the quarter.
Goldman Sachs BDC Trading Up 0.5 %
Shares of GSBD opened at $10.56 on Wednesday. Goldman Sachs BDC has a 1-year low of $9.51 and a 1-year high of $15.94. The company has a current ratio of 1.26, a quick ratio of 1.26 and a debt-to-equity ratio of 1.19. The firm’s 50-day moving average price is $11.33 and its 200-day moving average price is $12.30. The firm has a market capitalization of $1.24 billion, a price-to-earnings ratio of 15.08 and a beta of 0.71.
Goldman Sachs BDC Increases Dividend
The business also recently disclosed a quarterly dividend, which was paid on Monday, April 28th. Shareholders of record on Monday, March 31st were issued a $0.16 dividend. The ex-dividend date of this dividend was Monday, March 31st. This is a positive change from Goldman Sachs BDC’s previous quarterly dividend of $0.05. This represents a $0.64 annualized dividend and a yield of 6.06%. Goldman Sachs BDC’s dividend payout ratio (DPR) is 224.56%.
Wall Street Analysts Forecast Growth
Get Our Latest Report on Goldman Sachs BDC
About Goldman Sachs BDC
Goldman Sachs BDC, Inc is a business development company specializing in middle market and mezzanine investment in private companies. It seeks to make capital appreciation through direct originations of secured debt, senior secured debt, junior secured debt, including first lien, first lien/last-out unitranche and second lien debt, unsecured debt, including mezzanine debt and, to a lesser extent, investments in equities.
Read More
- Five stocks we like better than Goldman Sachs BDC
- High Dividend REITs: Are They an Ideal Way to Diversify?
- 3 Mid-Cap Medical Stocks Outperforming the Market
- Which Wall Street Analysts are the Most Accurate?
- The Top-Ranked Insider Buys From April by Market Cap
- Basic Materials Stocks Investing
- Is Eli Lilly a Buy After Weak Earnings and CVS-Novo Partnership?
Receive News & Ratings for Goldman Sachs BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Goldman Sachs BDC and related companies with MarketBeat.com's FREE daily email newsletter.